US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
WASHINGTON - The US Food and Drug Administration (FDA) is asking some of its recently fired scientists if they will come back ...
Exclusive-US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
devdiscourse8 小时
US Aid Freeze Disrupts Global Health Supply Chains; Mirum Pharma's Breakthrough, Eli Lilly ...
The US foreign aid freeze causes disruption in the supply chain for vital medical products in poorer countries, affecting diseases like HIV and malaria. Other health updates include FDA drug approvals ...
FDA Begins to Rescind Firings, Calls Some Employees Back to Work
The FDA late Friday started reversing termination notices for some employees that were laid off, informing workers to return ...
Novo’s Weight Loss Drugs Removed from FDA Shortage List
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...
Esperion Therapeutics: Little Upside Potential In Their Earlier Generation Drug
Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.
WBAL-TV1 天
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
FactChecking RFK Jr.'s first interview as HHS Secretary
In Robert F. Kennedy Jr.’s first interview as secretary of the Department of Health and Human Services, he made multiple ...
Correction to FDA Approves Mirum Pharmaceuticals Treatment Article
The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli, or chenodiol, to treat Cerebrotendinous Xanthoma, the agency said Friday. "FDA Approves Mirum Pharmaceuticals Treatment for ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
US FDA approves Mirum Pharma's genetic disorder drug
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...